Proactive - Interviews for investors
IBT portfolio manager says KalVista deal signals Biotech 2.0 growth
Ailsa Craig, portfolio manager at International Biotechnology Trust (IBT), discusses M&A activity in the biotech sector, citing the KalVista Pharmaceuticals acquisition as an example. She explains that biotech firms are being acquired by cash-rich big pharma companies looking…